Prescription Required
Gemer 1/500 mg Tablet is an oral anti-diabetic medication used for the management of type 2 diabetes mellitus. It contains Glimepiride (1 mg), a sulfonylurea, and Metformin (500 mg), a biguanide, which work together to lower blood sugar levels, improve insulin sensitivity, and prevent diabetes-related complications. It is commonly prescribed along with diet and lifestyle modifications for better diabetes control.
GEMER Tablet should be Use with caution in liver disease patients.
GEMER should be used very cautiously in patients with kidney disease. Dose adjustments needed for kidney impairment.
Avoid alcohol to reduce the risk of lactic acidosis.
May cause dizziness; avoid if affected.
GEMER tablet should not be taken by the preganant women, It is not recommended unless prescribed.
Gemer tablet should consult a doctor before use.
Gemer Tablet works by combining Glimepiride and Metformin to effectively control blood sugar levels in type 2 diabetes. Glimepiride stimulates the pancreas to release more insulin, helping lower blood glucose, while Metformin reduces glucose production in the liver and improves insulin sensitivity. This dual action helps the body utilize insulin efficiently, prevents complications, and supports long-term diabetes management.
Type 2 diabetes is a chronic condition where the body becomes resistant to insulin or does not produce enough, leading to high blood sugar levels. If left untreated, it can result in heart disease, kidney damage, vision loss, and nerve disorders.
Active Ingredients: Glimepiride (1 mg) + Metformin (500 mg)
Dosage Form: Tablet
Prescription Required: Yes
Administration Route: Oral
Gemer 1/500 mg Tablet is a combination anti-diabetic medication that effectively controls blood sugar levels, improves insulin response, and prevents diabetes complications in patients with type 2 diabetes mellitus.
Content Updated on
Thursday, 6 March, 2025Prescription Required
Simplify your healthcare journey with Indian Government's ABHA card. Get your card today!
Create ABHA